Skip to main content

Permira Adds Dr Bruno Strigini As Senior Advisor

Private equity firm Permira has added Dr Bruno Strigini to its team as a Senior Adviser, focusing on healthcare.

Strigini brings over 30 years of experience in healthcare with a track record in international executive leadership as President and CEO of Novartis Oncology from 2014 to 2018. He was previously President of Europe/Canada at Merck & Co, and also worked at Schering-Plough, UCB, and SmithKline Beecham, where his roles have included President of International operations, President of Japan and Asia-Pacific, Head of Global Marketing and Business Development, and Managing Director positions. He currently serves as Chairman of the board of Owkin, an AI and machine learning company specialising in healthcare and is a partner at OneHealth Partners, an advisory firm focused on capital raising and strategic transactions in the healthcare sector.

Silvia Oteri, Partner and Head of Healthcare at Permira, says: “Bruno’s knowledge, expertise and network in the pharma space together with his experience in growing sustainable global businesses will help us further strengthen our expertise and network to continue to successfully invest in the space backing successful, complex and disruptive businesses”.

Strigini added: “I’m delighted to be joining Permira as a Senior Adviser. The team has a strong track record of investing across the healthcare sector and I look forward to helping source and develop interesting proprietary investment opportunities globally”.

The Permira funds have deployed around €2.7bn in the healthcare sector to date. The funds recently agreed to acquire Neuraxpharm, a European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS). Permira had already invested in the space in the past few years with the funds’ investments in Cambrex in 2019, Quotient Sciences in the same year, and LSNE, a contract development and manufacturing organisation specialising in sterile lyophilisation and fill & finish. Other portfolio companies in the sector include Althea, a leading European independent medical equipment service provider, Corin, a tech enabled orthopaedic implant company and I-Med, a network of radiology clinics in Australia.

© The Sortino Group Ltd

All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.